Skip to content
Home/Contractors/Access To Advanced Health Institute

Federal Contractor Profile

Access To Advanced Health Institute

Federal contracting record: $40M obligated across 21 awards from 1 agencies, FY 2016–2026.

$40M
Total Obligated
21
Award Records
1
Agencies Served
7
NAICS Codes

Company Profile

Parent UEI (Unique Entity Identifier)

EMQ1ANLATYS6

CAGE Code

06UF1

Address

1616 EASTLAKE AVE E STE 400, SEATTLE, WA, 981023797

First Federal Award

Oct 27, 2015

Most Recent Award

Aug 31, 2026

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

Top NAICS Activity

  • 541714

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

    6 awards

    $26M
  • 541712

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)

    1 awards

    $7.9M
  • 541715

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

    2 awards

    $5.1M
  • 541711

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

    5 awards

    $858K
  • 325414

    BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

    5 awards

    $813K
  • 325413

    IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

    1 awards

    $4K
  • 325199

    ALL OTHER BASIC ORGANIC CHEMICAL MANUFACTURING

    1 awards

    -$2K

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Sep 10, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES$110K
Sep 10, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$113K
Aug 16, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES$841K
Jul 22, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$1.9M
Jun 26, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES$2.8M
Mar 20, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.$1.3M
Jan 9, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$780K
Aug 28, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$1.7M
Aug 28, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES$426K
Jul 5, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES$810K
Aug 23, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.$39K
Aug 1, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$3.5M
Nov 23, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.$3.6M
Sep 14, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714INFECTIOUS DISEASE RESEARCH INSTITUTE: R&D OF INTRANASAL ADMINISTRATION OF RNA VACCINES AGAINST RESPIRATORY PATHOGENS$749K
Sep 3, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID325414INVESTIGATIONAL PRODUCTS GLA-SE ADJUVANT FORMULATION AND LYOPHILIZED ID93 FROM IDRI FOR DAIDS-FUNDED CLINICAL TRIALS$781K
Jun 9, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$2.7M
Feb 18, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.$2.9M
Sep 24, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715BASE PERIOD, HARMONIZATION AND OPTIMIZATION OF STUDY PROTOCOLS AND ASSAY AND M72 BASE, MANUFACTURING ANDM72 OPTION 1A, MOUSE MODEL YEARS 1 AND 2.$5.7M
Aug 29, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$3.1M
Jul 26, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.$753K
Jan 29, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID325414IDRI VACCINE GRADE ADVUJANTPURCHASE 36 VIALS$11K
Jan 11, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714IN VITRO ASSESSMENTS OF ANTIMICROBIAL ACTIVITY.$3K
Sep 20, 2018Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711TAS::75 0140::TAS$343K
Sep 19, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.$2.7M
Aug 15, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541712IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS$2.3M

Want to win work like Access To Advanced Health Institute?

Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.